Presbia PLC (NasdaqGM:LENS) filed a shelf registration and intend to use the net proceeds for funding their U.S. staged pivotal trial for their microlens and microlens inserter, their commercialization efforts, research and development activities, product manufacturing, acquisitions or investments in businesses, products or technologies that are complementary to their own, increasing our working capital and capital expenditures.